![Charles H. Scoggin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Charles H.
Scoggin was the founder of Noble Molecules, Inc. founded in 2005, where he held the title of Chairman from 2009 to 2010.
He also worked as the Chief Executive Officer at Nivalis Therapeutics, Inc. and as a Director at Corgenix Medical Corp.
from 2006 to 2008.
Ehemalige bekannte Positionen von Charles H. Scoggin
| Unternehmen | Position | Ende |
|---|---|---|
| CORGENIX MEDICAL CORPORATION | Direktor/Vorstandsmitglied | 26.02.2008 |
Nivalis Therapeutics, Inc.
 Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Vorstandsvorsitzender | - |
Noble Molecules, Inc.
 Noble Molecules, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Corgenix Medical Corp.
 Corgenix Medical Corp. Medical SpecialtiesHealth Technology Manufactures and markets specialized diagnostics kits for pharmaceutical companies | Health Technology |
Noble Molecules, Inc.
Noble Molecules, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Health Technology |
Wählen Sie MarketScreener 
